0 Items
Select Page

Welcome to The Native Antigen Company

World leading infectious disease reagents from the experts

Whether you need cutting-edge reagents for your research or bulk products for manufacturing we can support your needs

Antigens, Antibodies, Immunoassays


We specialise in the development and manufacture of antigens, antibodies and immunoassays for viral and bacterial pathogens. We produce both native and recombinant antigens using our proprietary mammalian system and have decades of experience in bulk and scale production.

Custom and Contract Research Services


We can undertake custom projects to manufacture antigens and other proteins, prepare antibodies and develop immunoassays to support your R&D. Our development laboratories are fully staffed by a team of PhD molecular biologists and development scientists who are able to execute projects as short as a few days, through to long-term programmes of a year or more.

MXRA8 Receptor

Borrelia Antigens, Antibodies and Immunoassays

We now offer an extensive range of Borrelia burgdorferi antigens, antibodies and immunoassays. Our high-quality products are suitable for a range of laboratory research and vaccine development applications.

Zika Immunoassay Kit

Zika Total Antibody Immunoassay

Our new ELISA assay is a novel format for detecting serological responses to Zika, with excellent specificity and sensitivity. With an assay time of less than 2 hours, our kit is also appropriate for rapid use. This Zika assay is suitable for measuring responses in any species, making it an ideal choice for animal model studies.

Mammalian-Expressed Proteins

Dengue NS1s, VLPs and Antibodies

The Native Antigen Company offer an extensive range of Dengue virus proteins, prepared in our mammalian cell expression system. Our antigens and antibodies are used by leading IVD and pharmaceutical companies for manufacturing and R&D.

About The Native Antigen Company

The Native Antigen Company specialises in the development and manufacture of both native and recombinant antigens, antibodies and immunoassays for viruses and bacteria. Our antigens are used by leading pharmaceutical companies and IVD manufacturers in cutting-edge vaccine research and serology where proper folding and glycosylation are vital. As well as offering antigens from a rapidly expanding portfolio, we are increasing our range of highly specific antibodies and ELISA immunoassays. Our expertise is also available to customers on a contract basis for those needing custom protein manufacture in our proprietary mammalian cell protein expression system, together with antibody and immunoassay development.

New Immunofluorescence Data for our CMV, Yellow Fever and Ebola Antibodies

We recently teamed-up with Virology Research Services (VRS) who tested a large panel of our viral antibodies in immunofluorescence applications. This work was funded by the Medical Research Council (Proximity to Discovery Award for Knowledge Exchange) through the...

Why are ticks such good vectors of pathogens?

In this blog, Professor Patricia Nuttall discusses what makes ticks such effective vectors of pathogens and how we might prevent the spread of tick-borne diseases. About Patrica Nuttall Pat Nuttall is Emeritus Professor of Arbovirology in the Department of Zoology,...

Our Contract Services

How can we help with your project? While we are best known for our antigen and antibody products, our team has decades of experience in the field of native antigen and recombinant protein contract research, process development and bespoke production. We can undertake...

Perfecting Plasmid Production

 Buy some off-the-shelf LB, whack in your bugs, job done? Not so fast there, it turns out there are some subtleties in plasmid production that you may not have thought would exist as our R&D scientist Ludovic Laigle explains… As part of our R&D process, LB...

Dengue in 2019

What's going on with dengue? Dengue virus (DENV) has been in the news a lot recently. The number of reported cases continues to climb year-on-year and 2019 has been especially bad. Rio de Janeiro has seen a 45% increase in dengue cases in the first two months of 2019...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

13 + 6 =

Live Customer Feedback